Optic
San Francisco
About Optic
Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific and business due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $22.0M
- Funding stage: Seed
- Last round: Seed (Jul 2022)
- Website: bioptic.io
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Information Technology, Life Science, SaaS
Social Profiles
Canonical: https://fsome.com/organization/optic-26086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.